Safety and blood levels of repeated doses of IX-01 in healthy men; v1

• Research type

  Research Study

• Full title

  A double-blind, randomised, placebo-controlled, parallel group, dose escalation study to investigate the safety, toleration, and pharmacokinetics of multiple oral doses of IX-01 in healthy male subjects (HMR code: 13-011)

• IRAS ID

  140984

• Contact name

  Frans van den Berg

• Contact email

  vparker@hmrlondon.com

• Sponsor organisation

  Ixchelsis Ltd

• Eudract number

  2013-004017-40

• REC name

  Scotland A REC

• REC reference

  13/SS/0185

• Date of REC Opinion

  5 Nov 2013

• REC opinion

  Further Information Favourable Opinion